by Dr. Agresti | Jan 21, 2022 | Blog
Given the legalization of marijuana in many states, I wanted to have an open discussion on the ramifications and repercussions of its legalization, and why choosing to use might not be the best choice for everyone. Marijuana is so readily accepted everywhere now, in...
by Dr. Agresti | Jan 21, 2022 | Blog
Stress and anxiety helps individuals face threats, along with challenging circumstances, and it also helps individuals to deal with external threats. Nevertheless, some people are not so lucky as you and I, because they have to suffer from anxiety that persists over...
by Dr. Agresti | Jan 21, 2022 | Blog
This week, I could write a blog on the psychosocial ramifications of long term isolation, or the effects of fear of contracting coronavirus on people with anxiety disorder, or tips on how to ride this pandemic out. I could do any and all of that, but to be honest, I’m...
by Dr. Agresti | Jan 21, 2022 | Blog
Caplyta (lumateperone): New for Schizophrenia…and More? Before we talk about Caplyta (lumateperone), I want to announce that I take no remuneration of any kind from any pharmaceutical or healthcare company. I am providing the following information solely for...
by Dr. Agresti | Jan 21, 2022 | Blog
The Skinny on Psychostimulants, Part 3: Modafinil Over the past two weeks, we’ve been discussing the psychostimulants amphetamines and methylphenidate, which stimulate the central nervous system by increasing synaptic concentrations of the neurotransmitters dopamine...
